# A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Breast Cancer

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06790693

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.